Physician
Pain Institute of Southern Arizona Pisa PC
Pain Institute of Southern Arizona Pisa PC was paid $3.20M by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 60% of everything it billed.
33Billing provider infoPAIN INSTITUTE OF SOUTHERN ARIZONA PISA PC
TUCSON, AZ 85718
TUCSON, AZ 85718
33aNPI1861575078assigned 10/23/2006
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$3.20M
24GClaims79,674
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Arizona
Rank by total paid#5 of 28
Median peer was paid$308K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,212 | $224K | |
| 2019 | 9,408 | $312K | |
| 2020 | 10,219 | $397K | |
| 2021 | 14,162 | $620K | |
| 2022 | 16,979 | $706K | |
| 2023 | 13,120 | $551K | |
| 2024incomplete | 8,574 | $387K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 60% | 42,604 | 39,718 | $1.93M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 21,204 | 19,126 | $615K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15% | 5,799 | 5,388 | $468K |
| 62323 | <1% | 258 | 239 | $29K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 367 | 349 | $25K |
| 77002 | <1% | 313 | 275 | $21K | |
| 76942 | <1% | 568 | 529 | $20K | |
| 99205 | Prolong outpt/office vis | <1% | 193 | 176 | $18K |
| 99152 | <1% | 400 | 346 | $12K | |
| 20553 | <1% | 255 | 243 | $10K | |
| 64483 | <1% | 47 | 39 | $8K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,936 | 2,661 | $7K |
14 more codes
| 96127 | <1% | 1,718 | $7K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 356 | $6K |
| 20610 | <1% | 156 | $6K | |
| 64493 | <1% | 47 | $5K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 130 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 48 | $3K |
| 27096 | <1% | 17 | $2K | |
| 64494 | <1% | 13 | $850.93 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,728 | $603.94 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | $339.21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 385 | $334.56 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 52 | $189.52 |
| J3490 | Unclassified drugs | <1% | 29 | $94.25 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 39 | $80.74 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIRWIN, JENNIFER (MANAGING EMPLOYEE)